Back to search

Article

Vaccine effectiveness against mild and severe disease in pregnant mothers and their infants in England

2023-06-10

Abstract excerpt

<h4>Background</h4> Pregnant women are at increased risk of adverse outcomes following SARS-CoV-2 infection, including venous thromboembolism, admission to critical care and death. Their infants may also suffer from pre-term birth, stillbirth and severe disease. Vaccination may protect both mothers and their infants against severe COVID-19 disease. <h4>Methods</h4> We used a test-negative, case-control study desig...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b7daf925-bda2-531a-91eb-59758c0f307e
DOI
10.1101/2023.06.07.23290978
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Vaccine effectiveness against mild and severe disease in pregnant mothers and their infants in EnglandDOI 10.1101/2023.06.07.23290978
Effectiveness of the BNT162b2 mRNA COVID-19 Vaccine in PregnancySemantic proximity
Analysis of uptake, effectiveness and safety of COVID-19 vaccinations in pregnancy using the QResearch® database: research protocol and statistical analysis planSemantic proximity
Severity of maternal SARS-CoV-2 infection and perinatal outcomes during the Omicron variant dominant period: UK Obstetric Surveillance System national cohort studySemantic proximity
Maternal, perinatal, neonatal, and postpartum outcomes following SARS-CoV-2 infection in pregnancy: A WHO multi-country prospective cohort studySemantic proximity
Pregnancy and Infant Outcomes Following SARS-CoV-2 Infection in Pregnancy during Delta Variant Predominance – Surveillance for Emerging Threats to Pregnant People and InfantsSemantic proximity
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004)Semantic proximity
COVID-19 Severity among Women of Reproductive Age with Symptomatic Laboratory-Confirmed SARS-CoV-2 by Pregnancy Status – United States, Jan 1, 2020 – Sep 30, 2021Semantic proximity
Effectiveness of BNT162b2 mRNA COVID-19 Third Vaccines During Pregnancy: A National Observational Study in IsraelSemantic proximity
Maternal and Perinatal Outcomes Associated With the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) InfectionSemantic proximity
Maternal and Perinatal Outcomes of SARS-CoV-2 and Variants in PregnancySemantic proximity
Effectiveness of BNT162b2 mRNA COVID-19 third vaccines during pregnancy: A national observational study in IsraelSemantic proximity
Neonatal outcomes and indirect consequences following maternal SARS-CoV-2 infection in pregnancy: A systematic reviewSemantic proximity
Select a neighboring publication to make it the new centre.